A high-throughput microfluidic platform
The Infinity Screening System is a flexible, scalable, high-throughput microfluidic platform.
NemaLife created a future-proof life sciences platform by combining the top-notch technologies of our age, harnessing microfluidics, lab automation, machine learning aided image analysis, and data intelligence.
C. elegans is an established model organism for biological research, disease modeling, and drug discovery. NemaLife knows how laborious it can be to conduct whole-life assays and screening with C. elegans. Relying on our in-house microfluidics fabrication plant with funding from NIH, NSF, and NASA, we developed our patented core technology that offers unique benefits compared to agar, microplate, and even other microfluidics-based technologies.
LEARN MORE: NemaLife